Sleep Disorders
Benign sleep myoclonus of infancy
Apr. 08, 2024
This is an image preview.
Start a Free Account
to view the full image.
-
Nearly 3,000 illustrations, including video clips of neurologic disorders.
-
Every article is reviewed by our esteemed Editorial Board for accuracy and currency.
-
Full spectrum of neurology in 1,200 comprehensive articles.
-
Listen to MedLink on the go with Audio versions of each article.
Decarboxylation of l-glutamate to GABA catalyzed by glutamate decarboxylase
Pyridoxal 5'-phosphate is an essential cofactor for glutamic acid decarboxylase, which catalyzes the decarboxylation of glutamate to gamma-amino butyric acid and carbon dioxide. Because glutamate is an excitatory neurotransmitter, whereas GABA is an inhibitory neurotransmitter, the net effect of interfering with either pyridoxal 5-phosphate or GAD is to shift the balance of neural signaling to a more excitatory state. Because the metabolic product of the mushroom toxin gyromitrin, monomethylhydrazine, binds to and inhibits pyridoxal phosphokinase, can result in CNS excitation and seizures that are refractory to standard anticonvulsant therapy. Monomethylhydrazine may interfere with GABA synthesis by additional mechanisms: (1) inhibiting GAD directly; (2) inhibiting pyridoxine phosphokinase, which converts pyridoxine to its active form (pyridoxal-5'-phosphate). (Source: Yogeswara IBA, Maneerat S, Haltrich D. Glutamate decarboxylase from lactic acid bacteria-a key enzyme in GABA aynthesis. Microorganisms. 2020;8(12):1923. Creative Commons Attribution (CC BY) license.)